APOA1 and Parkinson disease: Deng et al. [7] found that serum apolipoprotein A1 levels were significantly elevated in Parkinson’s disease patients with mild cognitive impairment, and that serum apolipoprotein A1 levels were significantly negatively associated with MoCA score in patients with Parkinson’s disease.